High Court Shakes Head At Hytrin Settlement Case

Law360, New York (January 10, 2007, 12:00 AM EST) -- The U.S. Supreme Court has declined to take on the case of seven major health care providers who were seeking the right to opt out of a $15 million antitrust class action settlement over patent rights to the drug Hytrin after they missed a filing deadline due to a mail delay.

The High Court on Monday denied a petition for a writ of certiorari, giving no further details regarding its decision not to hear the case.

The news comes just three months after the appellants, referred...
To view the full article, register now.